Baker Brothers Advisors - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$3,860,000
+37.1%
22,4300.0%0.02%
+41.7%
Q2 2021$2,815,000
-7.5%
22,4300.0%0.01%
-7.7%
Q1 2021$3,042,000
+6.0%
22,4300.0%0.01%
+18.2%
Q4 2020$2,870,000
-0.5%
22,430
-12.5%
0.01%
-8.3%
Q3 2020$2,885,000
+12.2%
25,640
-5.0%
0.01%
+9.1%
Q2 2020$2,572,000
+6.0%
27,0000.0%0.01%
-26.7%
Q1 2020$2,426,000
-26.8%
27,000
-67.8%
0.02%
-34.8%
Q3 2019$3,315,000
-3.8%
83,9000.0%0.02%0.0%
Q2 2019$3,447,000
-11.8%
83,9000.0%0.02%
-8.0%
Q1 2019$3,907,000
+6.9%
83,9000.0%0.02%
-16.7%
Q4 2018$3,654,000
-23.9%
83,9000.0%0.03%
-6.2%
Q3 2018$4,802,000
-39.6%
83,900
-48.8%
0.03%
-46.7%
Q2 2018$7,952,000
+24.1%
163,9000.0%0.06%
+11.1%
Q1 2018$6,408,000
-7.9%
163,9000.0%0.05%
-10.0%
Q4 2017$6,956,000
+13.7%
163,9000.0%0.06%
+20.0%
Q3 2017$6,117,000
+599.9%
163,900
+469.8%
0.05%
+525.0%
Q2 2017$874,000
+14.8%
28,7650.0%0.01%
+33.3%
Q1 2017$761,000
+3.7%
28,7650.0%0.01%
-14.3%
Q4 2016$734,000
-29.5%
28,7650.0%0.01%
-22.2%
Q3 2016$1,041,000
+6.6%
28,7650.0%0.01%
-10.0%
Q2 2016$977,000
+28.7%
28,7650.0%0.01%
+25.0%
Q1 2016$759,000
-45.9%
28,7650.0%0.01%
-33.3%
Q4 2015$1,403,000
+95.9%
28,7650.0%0.01%
+71.4%
Q3 2015$716,000
-21.3%
28,7650.0%0.01%
-12.5%
Q2 2015$910,000
-16.9%
28,7650.0%0.01%
-11.1%
Q1 2015$1,095,000
-2.3%
28,7650.0%0.01%
-18.2%
Q4 2014$1,121,000
+28.9%
28,7650.0%0.01%0.0%
Q3 2014$870,000
-11.0%
28,7650.0%0.01%
-8.3%
Q2 2014$977,000
-1.5%
28,7650.0%0.01%
-7.7%
Q1 2014$992,000
-16.5%
28,765
-4.1%
0.01%
-23.5%
Q4 2013$1,188,00030,0000.02%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 2$3580.00%
View complete list of ACCELERON PHARMA INC shareholders